Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide.

Martin AJ, Dhillon HM, Vardy JL, Dalziell RA, Choy B, Fernández-Peñas P, Dixon A, Renton C, St George G, Chinniah N, Halliday GM, Damian DL, Chen AC.

Geriatrics (Basel). 2019 Mar 25;4(1). pii: E31. doi: 10.3390/geriatrics4010031.

2.

Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer.

Vardy JL, Dhillon HM, Pond GR, Renton C, Clarke SJ, Tannock IF.

ESMO Open. 2018 Feb 14;3(2):e000302. doi: 10.1136/esmoopen-2017-000302. eCollection 2018.

3.

Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.

Dhillon HM, Tannock IF, Pond GR, Renton C, Rourke SB, Vardy JL.

J Cancer Surviv. 2018 Apr;12(2):178-185. doi: 10.1007/s11764-017-0656-6. Epub 2017 Oct 27.

PMID:
29080061
4.

Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study.

Vardy JL, Dhillon HM, Pond GR, Rourke SB, Bekele T, Renton C, Dodd A, Zhang H, Beale P, Clarke S, Tannock IF.

J Clin Oncol. 2015 Dec 1;33(34):4085-92. doi: 10.1200/JCO.2015.63.0905. Epub 2015 Nov 2.

Supplemental Content

Loading ...
Support Center